Home » Authors » Mark Lawson

Mark Lawson

Articles

ARTICLES

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

View All Articles by Mark Lawson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...